Alomone Labs competitorsClear all

Alomone Labs's top competitors include GT Biopharma, Cidara Therapeutics, Reata Pharmaceuticals and Intercept Pharmaceuticals.
Alomone Labs
Alomone Labs
Alomone Labs is a company specializing in tools for membrane proteins.
GT Biopharma
GT Biopharma
GT Biopharma (formerly Oxis International) is engaged in the development of immunotherapies for cancer treatment.
Cidara Therapeutics
Cidara Therapeutics
Cidara is biotechnology focused on developing novel anti-infectives to address serious infections.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.
Intercept Pharmaceuticals
Intercept Pharmaceuticals
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.
Founding Date
Founding Date
1989
Founding Date
1965
Founding Date
2013
Founding Date
2002
Founding Date
2002
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
HQ
Locations
Tampa, US HQ
Beverly Hills, US
Locations
San Diego, US HQ
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
New York, US HQ
Wien, AT
Mississauga, CA
Kongens Lyngby, DK
Paris, FR
München, DE
Dublin, IE
see more
Employees
Employees
28
Employees
340% decrease
Employees
68
Employees
22079% increase
Employees
58321% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
9.5 m
Valuation ($)
154.2 m
Valuation ($)
5.2 b
Valuation ($)
1.5 b
Twitter followers
Twitter followers
20
Twitter followers
66
Twitter followers
3.4 k
Twitter followers
923
Twitter followers
2.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
7.1
Average likes per tweet (last 30 days)
3.6
Average likes per tweet (last 30 days)
6.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
91.67%
Percentage of tweets with engagement (last 30 days)
94.44%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
312591
Alexa Website Rank
379858
Alexa Website Rank
319599
Alexa Website Rank
229923
Alexa Website Rank
381339
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4
Employee Rating
3.1

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$26.5m (FY, 2019)
Revenue (est.)
$252m (FY, 2019)
Net income
Net income
N/A
Net income
($38.6m) (FY, 2019)
Net income
($41.1m) (FY, 2019)
Net income
($290.2m) (FY, 2019)
Net income
($344.7m) (FY, 2019)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
2 (FY, 2016)
Patents Issued
N/A
Patents Issued
240 (FY, 2016)
Patents Issued
N/A
Patents Pending
Patents Pending
N/A
Patents Pending
2 (FY, 2016)
Patents Pending
N/A
Patents Pending
280 (FY, 2016)
Patents Pending
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.4m
Total funding raised
$ 52m
Total funding raised
$ 468.9m
Total funding raised
$ 55m
For sources of this data, please see the company profile

View company profiles

GT Biopharma
HQ
Tampa, US
Employees
3↓ 40% decrease

GT Biopharma (formerly Oxis International) is engaged in the development of immunotherapies for cancer treatment.

View company
Cidara Therapeutics
HQ
San Diego, US
Employees
68

Cidara is biotechnology focused on developing novel anti-infectives to address serious infections.

View company
Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company focused on translating innovative science into breakthrough medicines for intractable diseases.

View company
Intercept Pharmaceuticals
HQ
New York, US
Employees
583↑ 21% increase

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.

View company